{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:52:05Z","timestamp":1793922725530,"version":"4.8.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100015471","name":"Mater Foundation","doi-asserted-by":"crossref","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100015471","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Spontaneous bacterial peritonitis (SBP), a common infection in patients with cirrhosis and ascites, is associated with high morbidity and mortality. The aim of this study was to investigate changes in the epidemiology of ascites fluid infections over time in an Australian population, including patient demographics, trends in mortality, length of hospital stay and the nature and antibiotic resistance profile of causative organisms.<\/jats:p>\n            <jats:p>An observational descriptive population-based epidemiological study of patients with cirrhosis admitted to public hospitals in Queensland during 2008\u20132017 was performed, linking demographic\/clinical and microbiology data.<\/jats:p>\n            <jats:p>Among 103,165 hospital admissions of patients with cirrhosis, ascites was present in 16,550 and in 60% (9977) a sample of ascitic fluid was tested. SBP was diagnosed in 770 admissions (neutrophil count &gt;250\/ml) and bacterascites in 552 (neutrophil count &lt;250\/ml with positive culture). The number of admissions with an ascites fluid infection increased by 76% from 2008 to 2017, paralleling an 84% increase in cirrhosis admissions over the same timeframe. Patients with SBP had a longer hospital stay (median 15.7 vs 8.3\u200adays for patients without SBP, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and higher in-hospital mortality, although this decreased from 39.5% in 2008 to 2010 to 24.8% in 2015 to 2017 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). Common Gram-positive isolates included coagulase negative staphylococci (37.9%), viridans group streptococci (12.1%), and <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> (7.2%). Common Gram-negative isolates included <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic> (13.0%), <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic> (3.1%) and <jats:italic toggle=\"yes\">Enterobacter cloacae<\/jats:italic> (2.6%). The prevalence of resistance to any tested antibiotic was &lt;10%.<\/jats:p>\n            <jats:p>SBP remains associated with high in-hospital mortality and long hospital stay. Typical skin and bowel pathogens were common, therefore, empirical antibiotic therapy should target these pathogens. This study provides valuable evidence informing infection management strategies in this vulnerable patient population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029217","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T14:02:50Z","timestamp":1653400970000},"page":"e29217","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Epidemiology of ascites fluid infections in patients with cirrhosis in Queensland, Australia from 2008 to 2017"],"prefix":"10.1097","volume":"101","author":[{"given":"Isanka U.","family":"Ratnasekera","sequence":"first","affiliation":[{"name":"Mater Research Institute, the University of Queensland, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, QLD, Australia"},{"name":"Centre for Liver Disease Research, Faculty of Medicine, the University of Queensland, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Powell","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, QLD, Australia"},{"name":"Centre for Liver Disease Research, Faculty of Medicine, the University of Queensland, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Henderson","sequence":"additional","affiliation":[{"name":"Infection Management Services, Princess Alexandra Hospital, Brisbane, Australia"},{"name":"University of Queensland Centre for Clinical Research, Herston, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6716-1605","authenticated-orcid":false,"given":"Katharine M.","family":"Irvine","sequence":"additional","affiliation":[{"name":"Mater Research Institute, the University of Queensland, Brisbane, QLD, Australia"},{"name":"Centre for Liver Disease Research, Faculty of Medicine, the University of Queensland, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C.","family":"Valery","sequence":"additional","affiliation":[{"name":"Centre for Liver Disease Research, Faculty of Medicine, the University of Queensland, Brisbane, QLD, Australia"},{"name":"QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J Hepatol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","article-title":"Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document","volume":"32","author":"Rimola","year":"2000","journal-title":"J Hepatol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J Hepatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jceh.2018.08.006","article-title":"Small intestinal bacterial overgrowth in patients with cirrhosis","volume":"9","author":"Ghosh","year":"2019","journal-title":"Journal of clinical and experimental hepatology"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0168-8278(88)80018-7","article-title":"Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence","volume":"28","author":"Llovet","year":"1998","journal-title":"J Hepatol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fimmu.2019.00293","article-title":"Causes and consequences of innate immune dysfunction in cirrhosis","volume":"10","author":"Irvine","year":"2019","journal-title":"Front Immunol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/liv.13929","article-title":"Bacterascites: a study of clinical features, microbiological findings, and clinical significance","volume":"38","author":"Oey","year":"2018","journal-title":"Liver Int"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/hep.1840120415","article-title":"Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis","volume":"12","author":"Runyon","year":"1990","journal-title":"Hepatology"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J Hepatol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study","volume":"55","author":"Fernandez","year":"2012","journal-title":"Hepatology"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide","volume":"156","author":"Piano","year":"2019","journal-title":"Gastroenterology"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4254\/wjh.v7.i7.916","article-title":"Multiresistant bacterial infections in liver cirrhosis: clinical impact and new empirical antibiotic treatment policies","volume":"7","author":"Acevedo","year":"2015","journal-title":"World J Hepatol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"Fernandez","year":"2019","journal-title":"J Hepatol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.3748\/wjg.v22.i15.4049","article-title":"Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia","volume":"22","author":"Alexopoulou","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12939-020-1144-6","article-title":"Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians","volume":"19","author":"Valery","year":"2020","journal-title":"Int J Equity Health"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"e000485","DOI":"10.1136\/bmjgast-2020-000485","article-title":"ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies","volume":"7","author":"Hayward","year":"2020","journal-title":"BMJ Open Gastroenterology"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Medical care"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.eclinm.2019.05.007","article-title":"Increasing hospitalization rates for cirrhosis: overrepresentation of disadvantaged australians","volume":"11","author":"Powell","year":"2019","journal-title":"EClinicalMedicine"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial","volume":"63","author":"Piano","year":"2016","journal-title":"Hepatology"},{"key":"R26-20250504","first-page":"661","article-title":"The current economic burden of cirrhosis","volume":"7","author":"Neff","year":"2011","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/ajg.2017.19","article-title":"Bacterial infections change natural history of cirrhosis irrespective of liver disease severity. Liver","volume":"112","author":"Dionigi","year":"2017","journal-title":"The Am J Gastroenterol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/liv.13645","article-title":"Infections complicating cirrhosis","volume":"38 Suppl 1","author":"Piano","year":"2018","journal-title":"Liver Int"},{"key":"R30-20250504","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000695","article-title":"Bacteraemia, sepsis and antibiotic resistance in Australian patients with cirrhosis: a population-based study","volume":"8","author":"Johnson","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s10620-018-4990-y","article-title":"Mortality from spontaneous bacterial peritonitis among hospitalized patients in the USA","volume":"63","author":"Niu","year":"2018","journal-title":"Dig Dis Sci"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1007\/s10620-017-4637-4","article-title":"Relative ascites polymorphonuclear cell count indicates bacterascites and risk of spontaneous bacterial peritonitis","volume":"62","author":"Lutz","year":"2017","journal-title":"Digestive diseases and sciences"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4254\/wjh.v9.i30.1166","article-title":"Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis","volume":"9","author":"Fiore","year":"2017","journal-title":"World J Hepatol"},{"key":"R34-20250504","doi-asserted-by":"crossref","DOI":"10.21037\/amj.2018.03.09","article-title":"Changing epidemiology in spontaneous bacterial peritonitis and challenging balance between new strategies in empirical antibiotics and emergence of resistant bacteria","volume":"3","author":"Lim","year":"2018","journal-title":"AME Medical Journal"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3349\/ymj.2020.61.2.145","article-title":"Culture-positive spontaneous ascitic infection in patients with acute decompensated cirrhosis: Multidrug-resistant pathogens and antibiotic strategies","volume":"61","author":"Liu","year":"2020","journal-title":"Yonsei Med J"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"10409","DOI":"10.3748\/wjg.v21.i36.10409","article-title":"Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients","volume":"21","author":"Li","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R38-20250504","first-page":"43","article-title":"Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2017","author":"Bell","year":"2019","journal-title":"Commun Dis Intell (2018)"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/jgh.13266","article-title":"Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis","volume":"31","author":"Friedrich","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1590\/s0004-2803.201800000-08","article-title":"Impact of microbiological changes on spontaneous bacterial peritonitis in three different periods over 17\u200ayears","volume":"55","author":"Almeida","year":"2018","journal-title":"Arq Gastroenterol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1471-2334-14-287","article-title":"Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study","volume":"14","author":"Piroth","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s12879-019-4102-4","article-title":"Causative agents and outcome of spontaneous bacterial peritonitis in cirrhotic patients: community-acquired versus nosocomial infections","volume":"19","author":"Ding","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1186\/s12879-019-4352-1","article-title":"VRE in cirrhotic patients","volume":"19","author":"Barger","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R44-20250504","first-page":"21","article-title":"Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis","volume":"28","author":"Lee","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2036.2012.05076.x","article-title":"Emergence of spontaneous bacterial peritonitis due to enterococci \u2013 risk factors and outcome in a 12-year retrospective study","volume":"35","author":"Reuken","year":"2012","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:04:51Z","timestamp":1746327891000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029217"}},"subtitle":["A population-based study"],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":41,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029217","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"2021-04-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}